Novo Nordisk pitted a new weight-loss drug against Eli Lilly’s — and lost
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug…
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug…
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online. www.bbc.com #039I #thought…
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.…
Piotr Swat | Lightrocket | Getty Images Hims & Hers on Saturday said that it will pull its copycat weight-loss…
Hims & Hers Health Inc. said it will stop selling its knockoff weight-loss pill just days after initially offering it,…
Novo Nordisk is predicting a 13% drop in sales in 2026. As the company’s patents on Ozempic expire, could cheaper,…
On today’s Big Take podcast: Novo Nordisk’s patents on Ozempic are starting to expire. What does that mean for the…
PepsiCo (PEP) CEO Ramon Laguarta will spend 2026 executing on a bold reinvention of the beverage and snack giant. “This…
Get caught up. www.bloomberg.com #Novo #Nordisk #Emerges #Big #Loser #WeightLoss #Drug #Battle
Recently-appointed CEO Mike Doustdar has repeatedly reset expectations since his arrival. Pricing and regulatory pressure is fierce and pessimistic revenue…